These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 39349930)
1. Elevated origin recognition complex subunit 6 expression promotes non-small cell lung cancer cell growth. Sang YH; Luo CY; Huang BT; Wu S; Shu J; Lan CG; Zhang F Cell Death Dis; 2024 Sep; 15(9):700. PubMed ID: 39349930 [TBL] [Abstract][Full Text] [Related]
2. Origin recognition complex 6 overexpression promotes growth of glioma cells. Yang WL; Zhang WF; Wang Y; Lou Y; Cai Y; Zhu J Cell Death Dis; 2024 Jul; 15(7):485. PubMed ID: 38971772 [TBL] [Abstract][Full Text] [Related]
3. Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Sun CC; Li SJ; Li DJ Oncotarget; 2016 Jun; 7(24):35960-35978. PubMed ID: 27166267 [TBL] [Abstract][Full Text] [Related]
4. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth. Zhou T; Sang YH; Cai S; Xu C; Shi MH Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320 [TBL] [Abstract][Full Text] [Related]
5. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis. Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957 [TBL] [Abstract][Full Text] [Related]
6. A miR-361-5p/ ORC6/ PLK1 axis regulates prostate cancer progression. Liu Z; Zhang Y; Yu L; Zhang Z; Li G Exp Cell Res; 2024 Jul; 440(1):114130. PubMed ID: 38885805 [TBL] [Abstract][Full Text] [Related]
7. The circular RNA NT5E promotes non-small cell lung cancer cell growth via sponging microRNA-134. Dong L; Zheng J; Gao Y; Zhou X; Song W; Huang J Aging (Albany NY); 2020 Feb; 12(4):3936-3949. PubMed ID: 32096481 [TBL] [Abstract][Full Text] [Related]
8. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600 [TBL] [Abstract][Full Text] [Related]
9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
10. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth. Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426 [TBL] [Abstract][Full Text] [Related]
11. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803 [TBL] [Abstract][Full Text] [Related]
12. Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling. Xiong H; Chen G; Fang K; Gu W; Qiu F Curr Cancer Drug Targets; 2024; 24(11):1128-1143. PubMed ID: 38299400 [TBL] [Abstract][Full Text] [Related]
13. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p. Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression. Zheng J; Zhang Y; Cai S; Dong L; Hu X; Chen MB; Zhu YH Cancer Lett; 2020 Apr; 476():129-139. PubMed ID: 32081805 [TBL] [Abstract][Full Text] [Related]
16. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis. Wei D; Sun L; Feng W Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
18. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway. Li WQ; Zhang JP; Wang YY; Li XZ; Sun L Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561 [TBL] [Abstract][Full Text] [Related]
20. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3. Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]